-
EP3487511
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3487511
| EP3487511 - AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.11.2021 Database last updated on 19.10.2024 | |
| Former | Examination is in progress Status updated on 04.03.2021 | ||
| Former | Request for examination was made Status updated on 26.04.2019 | ||
| Former | The international publication has been made Status updated on 03.02.2018 | Most recent event Tooltip | 05.11.2021 | Application deemed to be withdrawn | published on 08.12.2021 [2021/49] | Applicant(s) | For all designated states Cellular Approaches, Inc. 11099 North Torrey Pines Road, Suite 290 La Jolla CA 92037 / US | [2019/22] | Inventor(s) | 01 /
TURNER, Court c/o Cellular Approaches Inc. 11099 North Torrey Pines Road Suite 290 La Jolla, California 92037 / US | [2019/22] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
| Former [2019/22] | HGF Limited 8th Floor 140 London Wall London EC2Y 5DN / GB | Application number, filing date | 17835135.9 | 25.07.2017 | [2019/22] | WO2017US43782 | Priority number, date | US201662366474P | 25.07.2016 Original published format: US 201662366474 P | US201662366569P | 25.07.2016 Original published format: US 201662366569 P | US201762444760P | 10.01.2017 Original published format: US 201762444760 P | US201762456448P | 08.02.2017 Original published format: US 201762456448 P | US201762457681P | 10.02.2017 Original published format: US 201762457681 P | [2019/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018022651 | Date: | 01.02.2018 | Language: | EN | [2018/05] | Type: | A1 Application with search report | No.: | EP3487511 | Date: | 29.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.02.2018 takes the place of the publication of the European patent application. | [2019/22] | Search report(s) | International search report - published on: | KR | 01.02.2018 | (Supplementary) European search report - dispatched on: | EP | 28.02.2020 | Classification | IPC: | A61K35/15, A61K35/51, A61K31/22, A61K45/06, A61P31/04, A61K31/739, C12N5/0786 | [2020/13] | CPC: |
A61K35/51 (EP,US);
A61K2239/26 (EP,US);
A61K2239/31 (EP,US);
A61K2239/38 (EP,US);
A61K31/22 (EP);
A61K31/739 (EP);
A61K39/4614 (EP,US);
A61K39/4621 (EP,US);
A61K39/4622 (EP,US);
A61K39/46433 (EP,US);
A61K39/464818 (EP,US);
A61K39/464827 (EP);
A61K39/464838 (EP,US);
A61K45/06 (EP,US);
A61P31/04 (EP,US);
C12N5/0645 (EP,US);
C12N2501/052 (EP);
C12N2501/22 (EP);
| C-Set: |
A61K31/22, A61K2300/00 (EP);
A61K31/739, A61K2300/00 (EP);
A61K35/51, A61K2300/00 (EP)
|
| Former IPC [2019/22] | A61K35/14, A61K35/51, A61K35/28, A61K31/43, A61K45/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/22] | Title | German: | AUTOLOGE UND ALLOGENE MAKROPHAGEN UND MONOZYTEN ZUR VERWENDUNG IN THERAPEUTISCHEN VERFAHREN | [2019/22] | English: | AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS | [2019/22] | French: | MACROPHAGES ET MONOCYTES AUTOLOGUES ET ALLOGÉNIQUES DESTINÉS À ÊTRE UTILISÉS DANS DES MÉTHODES THÉRAPEUTIQUES | [2019/22] | Entry into regional phase | 14.01.2019 | National basic fee paid | 14.01.2019 | Search fee paid | 14.01.2019 | Designation fee(s) paid | 14.01.2019 | Examination fee paid | Examination procedure | 15.01.2019 | Examination requested [2019/22] | 28.09.2020 | Amendment by applicant (claims and/or description) | 03.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 14.07.2021 | Application deemed to be withdrawn, date of legal effect [2021/49] | 04.08.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/49] | Fees paid | Renewal fee | 29.07.2019 | Renewal fee patent year 03 | 27.07.2020 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2021 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]KR20050034510 ; | [Y]US5662899 (CHOKRI MOHAMED [FR], et al); | [Y]WO0045827 (IDM IMMUNO DESIGNED MOLECULES [FR], et al); | [X]EP1944361 (INST NAT SANTE RECH MED [FR]); | [Y]US2009217402 (BERNSTEIN KENNETH [US], et al); | International search | [XA]US2010081199 (SLUKVIN IGOR I [US], et al); | [X]US8647678 (HEMATTI PEIMAN [US], et al); | [X]KR20140041263 (SEOUL NAT UNIV HOSPITAL [KR]); |